Olga Libova, NP
Certified Nurse Midwife (Cnm) · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Lpch Medical Group Div of Lucile · 332 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Olga Libova’s office at (650) 498-7200 to ask if they take your plan before you enroll.
California Medical Board record
Licence G1470 · Cancelled
Licence status: Cancelled · since 1950 · Hahnemann University School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$3,722
Medicare paid this office $3,722 for 30 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 13 | $737 | $57 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 14 | $664 | $47 |
Who their Medicare patients are
30 Original Medicare patients in 2024. Average age 71 · Women 100% · Health risk score 0.78. At or below the middle of the specialty; the typical certified nurse midwife clinician is at 0.85.
The office billed $13,212, Medicare allowed $4,297 and paid $3,722; for 50 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 30 | 50 | 71 | 0.78 | $13,212 | $3,722 |
| 2023 | 47 | 74 | 76 | 0.85 | $28,636 | $4,253 |
| 2022 | 57 | 81 | 74 | 0.99 | $33,923 | $6,609 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 22 | $1,808 | $60 |
| Short return visit (20+ min) | 17 | $665 | $32 |
2022: 3 services
| New patient visit (45+ min) | 33 | $3,309 | $100 |
| Return visit (30+ min) | 19 | $1,772 | $77 |
| New patient visit (30+ min) | 17 | $1,078 | $63 |
Drugs they prescribed that Part D paid
$2,639
Pharmacies billed $2,639 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 23) in 2024. Too few prescriptions to compare fairly with other clinicians.
21 generic and fewer than 11 brand-name prescriptions · $2,639 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 15 | $1,010 | $67 |
Year by year
| 2024 | 23 | 16 | 0% (0) | None | $2,639 |
| 2023 | 66 | 20 | 0% (0) | None | $3,344 |
| 2022 | 55 | 16 | 0% (0) | 0% | $848 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 1 drug
| Zolpidem | 16 | $122 | $8 |
Money from drug and device companies
$262 in 2025
| 2025 | 3 | 4 | None | $262 |
| 2024 | 5 | 5 | None | $425 |
| 2023 | 5 | 6 | $1,745 | $2,204 |
| 2022 | 5 | 8 | None | $1,511 |
| 2021 | 2 | 2 | None | $131 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Pharmaceuticals | Spravato | $109 | 1 payment
|
| Biogen | Zurzuvae | $106 | 1 payment
|
| Abbvie | Epkinly | $46 | 2 payments
|
See all 4 published payments
| Janssen Pharmaceuticals | Meals · 2025-06-27 | Spravato | $109 |
| Abbvie | Meals · 2025-04-08 | Imbruvica | $21 |
| Abbvie | Meals · 2025-03-17 | Epkinly | $24 |
| Biogen | Meals · 2025-02-27 | Zurzuvae | $106 |
See earlier years (2024, 2023, 2022, 2021)
2024: $425
| Neurocrine Biosciences | Ingrezza | $136 | 1 payment
|
| Gilead Sciences | None | $125 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $122 | 1 payment
|
| Sumitomo Pharma America | Gemtesa | $23 | 1 payment
|
| Becton Dickinson and | None | $20 | 1 payment
|
2023: $2,204
| Sumitomo Pharma America | Myfembree | $1,768 | 2 payments
|
| Abbvie | Vraylar | $125 | 1 payment
|
| Otsuka Pharmaceutical Development & Commercialization | Jynarque | $125 | 1 payment
|
| Axsome Therapeutics | Sunosi | $99 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $88 | 1 payment
|
2022: $1,511
| Myovant Sciences | Myfembree | $1,105 | 4 payments
|
| Vertos Medical | Mild Device Kit | $128 | 1 payment
|
| Abbvie | Vraylar | $125 | 1 payment
|
| Amgen | Evenity | $125 | 1 payment
|
| Hologic | Acessa Provu System | $29 | 1 payment
|
2021: $131
| Biohaven Pharmaceuticals | Nurtec Odt | $109 | 1 payment
|
| Jazz Pharmaceuticals | Sunosi | $22 | 1 payment
|
Professional record
- NPI
- 1316072572
- Licence
- CA 1470California G1470: Cancelled
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Advanced practice midwife (367A00000X)
- Mailing address
- 1220 Miramonte Ave, Mountain View, CA, 94040
- NPI first listed
- 2007-02-21
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.